- Trials with a EudraCT protocol (98)
 - Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
 
		
	   		
	   		    
                    
                   	
                   	    98 result(s) found for: Radiation-induced cancer.
                    
                
			
   			
		
		Displaying page 1 of 5.
	
	
	| EudraCT Number: 2016-001790-33 | Sponsor Protocol Number: AGO/2016/005 | Start Date*: 2016-06-17 | 
| Sponsor Name:University Hospital Ghent | ||
| Full Title: A PHASE II, SINGLE-CENTRE, PROSPECTIVE EXPLORATORY TRIAL TO ASSESS THE EFFICACY OF LANREOTIDE AUTOGEL 120 MG IN THE SYMPTOMATIC TREATMENT OF ACUTE RADIATION INDUCED DIARRHEA | ||
| Medical condition: radiation induced diarrhoea | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2011-003958-85 | Sponsor Protocol Number: IMM-101-007 | Start Date*: 2012-02-03 | |||||||||||
| Sponsor Name:Immodulon Therapeutics Ltd | |||||||||||||
| Full Title: A Phase II, Single Arm, Investigative Study of IMM-101 in Combination with Radiation Induced Tumour Necrosis in Patients with Previously Treated Colorectal Cancer | |||||||||||||
| Medical condition: Metastatic colorectal cancer | |||||||||||||
					
						
							
  | 
			|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2018-003856-19 | Sponsor Protocol Number: CVB2018-2 | Start Date*: 2019-01-09 | |||||||||||
| Sponsor Name:Department of Otorhinolaryngology, Head and Neck Surgery and Audiology. Rigshospitalet, University Hospital of Cph, DK | |||||||||||||
| Full Title: A Phase I Open Label Study Evaluating the Safety and Feasibility of Allogeneic Mesenchymal stem cells for radiation-induced hyposalivation and xerostomia in previous oropharyngeal patients | |||||||||||||
| Medical condition: The trial will include participants with Xerostomia ( International Classification of Diseases-10: DQ 838A) | |||||||||||||
					
						
							
  | 
			|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DK (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2004-004952-38 | Sponsor Protocol Number: MREC/04/4/016 | Start Date*: 2005-02-11 | 
| Sponsor Name:Prof John Yarnold, Institute of Cancer Research | ||
| Full Title: Randomised phase II trial of hyperbaric oxygen therapy in patients with chronic arm lymphoedema after radiotherapy for early breast cancer (HOT) | ||
| Medical condition: Chronic radiation-induced arm lymphoedema. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2010-023293-39 | Sponsor Protocol Number: RICH-ART | Start Date*: 2010-11-26 | 
| Sponsor Name:Västra Götalandsregionen, Shalgrenska University Hospital Östra | ||
| Full Title: | ||
| Medical condition: Radiation Cystitis | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-003591-38 | Sponsor Protocol Number: D4200C00045 | Start Date*: 2005-11-22 | 
| Sponsor Name:AstraZeneca AB | ||
| Full Title: A phase II, double-blind, placebo controlled, randomised study to assess the efficacy and safety of ZD6474 in combination with Arimidex vs. Arimidex alone in patients with hormone sensitive (ER+ve ... | ||
| Medical condition: Hormone sensitive (ER+ve and/ or PR +ve) advanced breast cancer (ABC) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Female | |
| Trial protocol: SE (Prematurely Ended) HU (Prematurely Ended) ES (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2007-000163-26 | Sponsor Protocol Number: HS-05-161 | Start Date*: 2008-08-01 | |||||||||||
| Sponsor Name:Camurus AB | |||||||||||||
| Full Title: A randomised, two-period cross-over, multicentre, double-blind, single-dose, placebo-controlled study to assess the local analgesic effect of CAM2028 in head-and-neck cancer patients suffering from... | |||||||||||||
| Medical condition: Head-and-neck cancer patients suffering from radiation-indused oral mucositis | |||||||||||||
					
						
							
  | 
			|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: BG (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2020-003306-32 | Sponsor Protocol Number: 030(Z)WO19247 | Start Date*: 2021-01-18 | |||||||||||
| Sponsor Name:Angelini Pharma S.p.A. | |||||||||||||
| Full Title: Phase IV study on the feasibility of a preventative/therapeutic approach with Benzydamine Oromucosal solution in radiation-induced Oral Mucositis (OM) in patients with head and neck cancer (HNC) | |||||||||||||
| Medical condition: Oral Mucositis (OM) in patients with head and neck cancer (HNC) | |||||||||||||
					
						
							
  | 
			|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: HU (Completed) PL (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2007-003894-18 | Sponsor Protocol Number: M07CCL | Start Date*: 2008-01-30 | 
| Sponsor Name:NKI-AVL | ||
| Full Title: Open-label, randomised, multi-center study investigating Cetuximab, in combination with concurrent chemo- / radiotherapy in locally advanced non-small cell lung carcinoma | ||
| Medical condition: Non-small cell lung cancer locally advanced | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2008-002985-70 | Sponsor Protocol Number: MD-R20080507 | Start Date*: 2009-04-23 | 
| Sponsor Name:University of Magdeburg | ||
| Full Title: Evaluation of the preventive effect of pentoxifylline and ursodeoxycholic acid to radiation induced liver toxicity after brachytherapy of liver metastases, assessed in a prospective randomised trial. | ||
| Medical condition: Irradiation damage to the liver after HDR-brachytherapy of liver metastases. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2008-002152-26 | Sponsor Protocol Number: ISRCTN86894066 | Start Date*: 2009-01-20 | |||||||||||
| Sponsor Name:The Royal Marsden Foundation Trust and The Institute of Cancer Research | |||||||||||||
| Full Title: Randomised double-blind controlled phase III trial of hyperbaric oxygen therapy in patients suffering long-term adverse effects of radiotherapy for pelvic cancer | |||||||||||||
| Medical condition: Chronic radiation-induced gastrointestinal symptoms | |||||||||||||
					
						
							
  | 
			|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2020-005465-13 | Sponsor Protocol Number: NL74804.091.21 | Start Date*: 2021-11-16 | 
| Sponsor Name:Radboudumc | ||
| Full Title: Cemiplimab treatment in patients with locally advanced and metastatic secondary angiosarcomas | ||
| Medical condition: Patients with locally advanced and metastatic secondary angiosarcomas | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-001045-40 | Sponsor Protocol Number: GEM-1805 | Start Date*: 2020-03-03 | |||||||||||
| Sponsor Name:Grupo Español Multidisciplinar de Melanoma | |||||||||||||
| Full Title: Phase II, Open-Label Study of preliminary efficacy of Durvalumab (MEDI4736) in Combination with Cediranib in Patients with Metastatic Uveal Melanoma | |||||||||||||
| Medical condition: Metastatic uveal melanoma | |||||||||||||
					
						
							
  | 
			|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2018-001153-27 | Sponsor Protocol Number: PenVe | Start Date*: 2019-02-22 | |||||||||||||||||||||
| Sponsor Name:Guy's and St Thomas' NHS Foundation Trust | |||||||||||||||||||||||
| Full Title: A feasibility study of a prospective randomised controlled trial comparing the use of open label pentoxifylline and tocopherol versus current standard of care for the prevention of fibrosis related... | |||||||||||||||||||||||
| Medical condition: Osteoradionecrosis, trismus and dysphagia | |||||||||||||||||||||||
					
						
							
  | 
			|||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||||||||||||
| Trial results: View results | |||||||||||||||||||||||
| EudraCT Number: 2012-004211-31 | Sponsor Protocol Number: CCR3894 | Start Date*: 2014-08-20 | 
| Sponsor Name:The Royal Marsden NHS Foundation Trust | ||
| Full Title: Randomised double-blind controlled phase II trial of Tocovid SupraBio in combination with pentoxifylline (PTX) in patients suffering long-term adverse effects of radiotherapy for pelvic cancer | ||
| Medical condition: Adverse effects of radiotherapy for pelvic cancer. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2014-004349-29 | Sponsor Protocol Number: 01-10-2014 | Start Date*: 2015-04-01 | ||||||||||||||||
| Sponsor Name:Rigshospitalet | ||||||||||||||||||
| Full Title: Mesenchymal stem cells for radiation-induced xerostomia (MESRIX) in previous HPV-positive oropharyngeal head and neck cancer patients | ||||||||||||||||||
| Medical condition: The study will include participants with xerostomi (International Classification of Diseases-10: DQ 838A) and oropharyngeal cancer (DC 10). | ||||||||||||||||||
					
						
							
  | 
			||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | |||||||||||||||||
| Trial protocol: DK (Completed) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2012-001381-15 | Sponsor Protocol Number: RICH-ART | Start Date*: 2012-06-13 | |||||||||||
| Sponsor Name:Sahlgrenska University Hospital Västra Götalandsregionen | |||||||||||||
| Full Title: Radiation Induced Cystits treated with Hyperbaric Oxygen. A Randomized controlled Trial | |||||||||||||
| Medical condition: Radiation Cystitis | |||||||||||||
					
						
							
  | 
			|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: SE (Completed) DK (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2007-001152-39 | Sponsor Protocol Number: SSG XX | Start Date*: 2024-05-21 | 
| Sponsor Name:Scandinavian Sarcoma Group | ||
| Full Title: SSGXX A Scandinavian Sarcoma Group treatment protocol for adult patients with non-metastatic high-risk soft tissue sarcoma of the extremities and trunk wall | ||
| Medical condition: SSG XX is a phase II trial for high-risk soft tissue sarcoma(STS) of the extremities and trunk wall. Prognostic markers are used to identify high-risk tumors. SSG XX will evaluate chemo-and radioth... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NO (Completed) SE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-000617-20 | Sponsor Protocol Number: MITO31 | Start Date*: 2018-11-14 | |||||||||||
| Sponsor Name:ISTITUTO NAZIONALE TUMORI - IRCCS FONDAZIONE PASCALE | |||||||||||||
| Full Title: A phase II trial of Olaparib in patients with recurrent ovarian cancer wild type for germline and somatic BRCA 1 and 2 genes: The MITO 31 transalational study. | |||||||||||||
| Medical condition: patients with recurrent ovarian cancer wild type for germline and somatic BRCA 1 and 2 genes | |||||||||||||
					
						
							
  | 
			|||||||||||||
| Population Age: Adults, Elderly | Gender: Female | ||||||||||||
| Trial protocol: IT (Trial now transitioned) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2018-001660-29 | Sponsor Protocol Number: FAB18 | Start Date*: 2019-01-16 | |||||||||||
| Sponsor Name:Leiden University Medical Center | |||||||||||||
| Full Title: FAB: Functional Analysis of BRCAness | |||||||||||||
| Medical condition: Recurrent epithelial ovarian cancer | |||||||||||||
					
						
							
  | 
			|||||||||||||
| Population Age: Adults, Elderly | Gender: Female | ||||||||||||
| Trial protocol: NL (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
			Subscribe to this Search
To subscribe to the RSS feed for this search click here
			.
			This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
		
			
To subscribe to the RSS feed for this search click here
			.
			This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
		| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
    	Query did not match any studies.